Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

Here are eight things for ASCs to know about the sale: 1. Stryker's U.S. spine segment will be sold to investment firm Viscogliosi Brothers. 2. That group will create VB Spine, which will be a ...

Stryker's Mako shoulder robot earned FDA approval in December, Jason Beach, vice president of finance and investor relations, said in a Jan. 28 earnings call.

Analyst Patrick Wood from Morgan Stanley maintained a Buy rating on Stryker (SYK – Research Report) and keeping the price target at ...